Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.
Zocco MA, dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, Novi M, Rigante D, Cazzato IA, Ojetti V, Armuzzi A, Gasbarrini G, Gasbarrini A. Zocco MA, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1567-74. doi: 10.1111/j.1365-2036.2006.02927.x. Aliment Pharmacol Ther. 2006. PMID: 16696804 Free article. Clinical Trial.
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.
Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. Armuzzi A, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2001 Feb;15(2):163-9. doi: 10.1046/j.1365-2036.2001.00923.x. Aliment Pharmacol Ther. 2001. PMID: 11148433 Free article. Clinical Trial.
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
Di Caro S, Ojetti V, Zocco MA, Cremonini F, Bartolozzi F, Candelli M, Lupascu A, Nista EC, Cammarota G, Gasbarrini A. Di Caro S, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2002 Mar;16(3):527-32. doi: 10.1046/j.1365-2036.2002.01165.x. Aliment Pharmacol Ther. 2002. PMID: 11876707 Free article. Clinical Trial.
Review article: breath testing for human liver function assessment.
Armuzzi A, Candelli M, Zocco MA, Andreoli A, De Lorenzo A, Nista EC, Miele L, Cremonini F, Cazzato IA, Grieco A, Gasbarrini G, Gasbarrini A. Armuzzi A, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2002 Dec;16(12):1977-96. doi: 10.1046/j.1365-2036.2002.01374.x. Aliment Pharmacol Ther. 2002. PMID: 12452932 Free article. Review.
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.
Nista EC, Candelli M, Cremonini F, Cazzato IA, Di Caro S, Gabrielli M, Santarelli L, Zocco MA, Ojetti V, Carloni E, Cammarota G, Gasbarrini G, Gasbarrini A. Nista EC, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2003 Sep 15;18(6):627-33. doi: 10.1046/j.1365-2036.2003.01676.x. Aliment Pharmacol Ther. 2003. PMID: 12969089 Free article. Clinical Trial.
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, Cammarota G, Gasbarrini G, Gasbarrini A. Nista EC, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1181-8. doi: 10.1111/j.1365-2036.2004.02274.x. Aliment Pharmacol Ther. 2004. PMID: 15569121 Free article. Clinical Trial.
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
Nista EC, Candelli M, Zocco MA, Cazzato IA, Cremonini F, Ojetti V, Santoro M, Finizio R, Pignataro G, Cammarota G, Gasbarrini G, Gasbarrini A. Nista EC, et al. Among authors: cremonini f. Aliment Pharmacol Ther. 2005 May 15;21(10):1241-7. doi: 10.1111/j.1365-2036.2005.02412.x. Aliment Pharmacol Ther. 2005. PMID: 15882245 Free article. Clinical Trial.
147 results